SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001280776-24-000009
Filing Date
2024-05-08
Accepted
2024-05-08 07:20:20
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vtl-20240331.htm   iXBRL 10-Q 763763
2 EX-31.1 imux-33124xexhibit311.htm EX-31.1 8515
3 EX-31.2 imux-33124xexhibit312.htm EX-31.2 8504
4 EX-32.1 imux-3x31x24xexhibit321.htm EX-32.1 4808
5 EX-32.2 imux-33124xexhibit322.htm EX-32.2 4785
11 vtl-20240331_g1.jpg GRAPHIC 188853
  Complete submission text file 0001280776-24-000009.txt   5434038

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtl-20240331.xsd EX-101.SCH 42775
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtl-20240331_cal.xml EX-101.CAL 49045
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtl-20240331_def.xml EX-101.DEF 218742
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtl-20240331_lab.xml EX-101.LAB 480747
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtl-20240331_pre.xml EX-101.PRE 359470
69 EXTRACTED XBRL INSTANCE DOCUMENT vtl-20240331_htm.xml XML 559325
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36201 | Film No.: 24924240
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)